Evidence map›Paper›PMID 37762043›Full record

ArticleInternational journal of molecular sciences2023

Synthesis and Study of Organic Nanostructures Fabricated by Inclusion of 2-Methylbenzimidazole Molecules in Nanotubes of Chrysotile Asbestos, Mesoporous Silica, and Nanopores of Borate Glasses.

Elena Balashova, Aleksandr A Levin, Sergey Pavlov, Anatoly Starukhin, Alexander Fokin, Dmitry Kurdyukov, Daniil Eurov, Boris Krichevtsov

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elena BalashovaIoffe Institute, Russian Academy of Sciences, Politechnicheskaya 26, 194021 Saint Petersburg, Russia.ORCID 0000-0003-4552-6762
Aleksandr A LevinIoffe Institute, Russian Academy of Sciences, Politechnicheskaya 26, 194021 Saint Petersburg, Russia.ORCID 0000-0001-9258-3204
Sergey PavlovIoffe Institute, Russian Academy of Sciences, Politechnicheskaya 26, 194021 Saint Petersburg, Russia.ORCID 0000-0001-9589-8017
Anatoly StarukhinIoffe Institute, Russian Academy of Sciences, Politechnicheskaya 26, 194021 Saint Petersburg, Russia.ORCID 0000-0002-4686-2891
Alexander FokinIoffe Institute, Russian Academy of Sciences, Politechnicheskaya 26, 194021 Saint Petersburg, Russia.
Dmitry KurdyukovIoffe Institute, Russian Academy of Sciences, Politechnicheskaya 26, 194021 Saint Petersburg, Russia.
Daniil EurovIoffe Institute, Russian Academy of Sciences, Politechnicheskaya 26, 194021 Saint Petersburg, Russia.
Boris KrichevtsovIoffe Institute, Russian Academy of Sciences, Politechnicheskaya 26, 194021 Saint Petersburg, Russia.ORCID 0000-0003-4032-8708

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New organic nanostructures were synthesized by introducing 2-methylbenzimidazole (MBI) molecules from a melt, gas phase, or alcoholic solution into nanosized voids of borate porous glasses (PG), nanotubes of chrysotile asbestos (ChA), and mesoporous silica (MS). The incorporation of MBI into borate glasses with different pore sizes is accompanied by the appearance of several phases formed by nanocrystallites which have a MBI crystal structure, but somewhat differ in lattice parameters. The size of some crystallites significantly exceeds the size of nanopores, which indicates the presence of long-scale correlations of the crystal structure. The size of MBI nanocrystallites in ChA was close to the diameter of nanotubes (

Indexed as

NanoporesNanotubesAsbestos, SerpentineBenzimidazolesBoratesSilicon Dioxide2-methylbenzimidazoleAsbestos, SerpentineBenzimidazolesBoratesSilicon Dioxide2-methylbenzimidazolecrystal structuredielectric propertiesFTIRorganic nanostructuresphotoluminescenceXRD

Identifiers

PMID37762043
PMCPMC10531229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.